News for 'Global Hospitals'

Record 73,642 COVID-19 patients recover in 24 hrs

Record 73,642 COVID-19 patients recover in 24 hrs

Rediff.com6 Sep 2020

"The spike in the daily recovered COVID-19 patients continues in the country. For the second successive day, India has clocked a record recovery of more than 70,000 patients in a single day," the government said.

Covid vaccine could cost up to Rs 1000 in private market

Covid vaccine could cost up to Rs 1000 in private market

Rediff.com28 Apr 2021

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.

How we can DEFEAT COVID-19

How we can DEFEAT COVID-19

Rediff.com17 Mar 2021

'If people are not cooperating and do not follow policies laid down by the government or follow scientific infection control management, then all will be lost.'

Planning To Buy Critical Illness Plan? Read this

Planning To Buy Critical Illness Plan? Read this

Rediff.com7 Jun 2022

'A policy that covers a wider range of diseases will offer greater peace of mind.'

Covid SOPs to be decided with Centre: Ajit Pawar

Covid SOPs to be decided with Centre: Ajit Pawar

Rediff.com2 Dec 2021

Maharashtra Deputy Chief Minister Ajit Pawar on Thursday said future decisions on COVID-19 SOPs will be taken in consultation with the Union Health Ministry and the state Task Force, amid a difference between the Centre and the state over guidelines for international travellers in the wake of the new variant of SARS-CoV2.

HR GURU: 'I work hard but don't get positive feedback'

HR GURU: 'I work hard but don't get positive feedback'

Rediff.com13 Sep 2022

'Have a candid discussion with your management and raise your concerns,' suggests HR Guru Mayank Rautela.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

Bird Group's ambitious plan to grab Air India's ground handling arm

Bird Group's ambitious plan to grab Air India's ground handling arm

Rediff.com16 Apr 2021

The promoter-brothers, distant cousins to IndiGo's Rahul Bhatia, are eyeing Air India's ground handling subsidiary to augment their aviation services business even as they make a big play in EVs.

'Brilliant businesses were not built on money, but on great ideas'

'Brilliant businesses were not built on money, but on great ideas'

Rediff.com6 Feb 2023

'People will say a lot of things -- ignore the noise.'

Jaipur's Raj Palace in global elite list

Jaipur's Raj Palace in global elite list

Rediff.com30 Mar 2007

Riding high on the international hospitality wave, India has once again figured in the list of world's best small luxury hotels with Jaipur's Raj Palace becoming the sixth hotel to enter the coveted group.

Remdesivir didn't cut mortality in Covid patients: WHO

Remdesivir didn't cut mortality in Covid patients: WHO

Rediff.com16 Oct 2020

The interim findings of the trial in which the four drugs were tested in 405 hospitals across 30 countries, covering 11,266 adults, were released on 'medRxiv', a preprint server, on Thursday. The findings are under review for publication in a medical journal.

ASK HR GURU: How To Deal With Office Politics?

ASK HR GURU: How To Deal With Office Politics?

Rediff.com12 Oct 2022

Office politics exists in many organisations, so don't let that bother you, advises HR Guru Mayank Rautela.

Will 5G turn the tables for India's telecom companies?

Will 5G turn the tables for India's telecom companies?

Rediff.com30 Mar 2022

Consumers can expect a 5G launch in the country soon. Telecom companies (telcos) say if auctions take place on time - the target is July - they would be able to offer some services in a few cities by the end of this year and a full roll-out from 2023. But the question is: will 5G turn the tables for telcos financially? Will average revenue per user (ARPU) improve? Will mobile consumers upgrade to 5G quickly and pay more? Will the expanded functions that 5G enables drum up sufficient revenues? In simple terms, will telcos make more money?

Omicron more infectious than Delta variant: Report

Omicron more infectious than Delta variant: Report

Rediff.com6 Dec 2021

'This means that there is a higher likelihood of individuals who have recovered from COVID-19 to be reinfected with the Omicron variant'

Chinese city sounds alert for bubonic plague

Chinese city sounds alert for bubonic plague

Rediff.com5 Jul 2020

Bayannur, Inner Mongolia Autonomous Region, announced a level III warning of plague prevention and control, state-run People's Daily Online reported. The suspected bubonic plague case was reported on Saturday by a hospital in Bayannur.

9 Heart Symptoms You Shouldn't Ignore

9 Heart Symptoms You Shouldn't Ignore

Rediff.com6 Jul 2022

The secret to a healthy heart lies in living a stress-free, well-balanced lifestyle combined with regular physical activity and a good night's sleep, suggests cardiologist Dr Talha Meeran.

Immediately sending whole series of help to India: Biden

Immediately sending whole series of help to India: Biden

Rediff.com28 Apr 2021

The president said he had discussed with Prime Minister Modi on when the US would be able to send actual vaccines to India.

Death toll in China's coronavirus jumps to 2,236

Death toll in China's coronavirus jumps to 2,236

Rediff.com21 Feb 2020

The overall confirmed infection cases have climbed to 75,465, Chinese health officials said on Friday.

No need to panic: Experts as Covid cases rise among kids

No need to panic: Experts as Covid cases rise among kids

Rediff.com16 Apr 2022

Kids mostly have mild illnesses and recover with just symptomatic treatment.

Explained: What is monkeypox?

Explained: What is monkeypox?

Rediff.com20 May 2022

Monkeypox is a rare zoonotic disease that is caused by infection with monkeypox virus. Monkeypox virus belongs to the family Poxviridae, which also includes the viruses causing smallpox and cowpox disease

What Will 2022 Bring The World?

What Will 2022 Bring The World?

Rediff.com1 Jan 2022

From Covid to climate change, Shankar Acharya's look at some of the trends and events that might shape 2022.

10 tips to be careful about hypertension

10 tips to be careful about hypertension

Rediff.com18 May 2021

Dr Praveen Kulkarni, senior cardiologist at Global Hospital, Mumbai explains why youngsters need to be careful about their lifestyle to prevent hypertension.

Expert warns of more virulent coronavirus after milder Omicron

Expert warns of more virulent coronavirus after milder Omicron

Rediff.com7 Jan 2022

The reduced severity of Omicron is good news for now, but it is the result of an "evolutionary mistake" as Covid-19 is transmitting very efficiently and there is no reason for it to become milder, indicating that the next variant could be more virulent, a leading Indian-origin scientist from the University of Cambridge has warned.

Producing vaccines is not like making 2 minutes noodles

Producing vaccines is not like making 2 minutes noodles

Rediff.com27 May 2021

'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.

Father of Pakistan's nuclear bomb AQ Khan passes away at 85

Father of Pakistan's nuclear bomb AQ Khan passes away at 85

Rediff.com10 Oct 2021

AQ Khan, a controversial scientist known as the father of Pakistan's clandestine nuclear programme, passed away here on Sunday after a brief illness. He was 85.

Biden administration comes under pressure to ship Covid vaccine to India

Biden administration comes under pressure to ship Covid vaccine to India

Rediff.com24 Apr 2021

The Joe Biden administration has come under intense pressure from various quarters, including the powerful US Chambers of Commerce, lawmakers and eminent Indian-Americans, to ship AstraZeneca and other Covid-19 vaccines along with several life-saving medical supplies to India, which is witnessing a deadly surge in coronavirus cases.

J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Rediff.com9 Apr 2021

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

Follow revised state travel rules, BMC tells Mumbai airport

Follow revised state travel rules, BMC tells Mumbai airport

Rediff.com2 Dec 2021

With the Maharashtra government on Thursday amending its air travel rules in view of global concerns over the Omicron variant of coronavirus, the Brihanmumbai Municipal Corporation cancelled its previous guidelines issued to the city airport authorities and asked them to follow the revised ones as issued by the state.

Serum to supply 22cr Covishield doses to Centre in October

Serum to supply 22cr Covishield doses to Centre in October

Rediff.com21 Sep 2021

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said.

Govt relaxes procurement norms for health, pharma ministries, DRDO

Govt relaxes procurement norms for health, pharma ministries, DRDO

Rediff.com10 May 2021

With the world's worst outbreak of COVID-19 severely straining the health system in the country, the government has made sweeping changes in the way departments procure medical supplies, including allowing procurement of the same item at different rates.

Xi makes first visit to coronavirus-hit Wuhan

Xi makes first visit to coronavirus-hit Wuhan

Rediff.com10 Mar 2020

Xi, also the general secretary of the ruling Communist Party of China, arrived in Wuhan, the epicentre of the virus outbreak, on Tuesday for an inspection of the epidemic prevention and control work in Hubei province and its capital city Wuhan, state-run Xinhua news agency reported.

Bharat Biotech to manufacture 1 billion Covaxin jabs per year

Bharat Biotech to manufacture 1 billion Covaxin jabs per year

Rediff.com21 May 2021

Bharat Biotech on Thursday said it plans to produce additional 200 million doses of COVID-19 vaccine 'Covaxin' at its subsidiary's Ankleshwar (Gujarat) based facility, taking the overall production volume of the vaccine to 1 billion (100 crore) dosages per annum.

Senior diplomat heads Indian team to Kabul on first visit since Taliban takeover

Senior diplomat heads Indian team to Kabul on first visit since Taliban takeover

Rediff.com2 Jun 2022

India has sent a team to Kabul to oversee the delivery of India's humanitarian assistance to Afghanistan and hold discussions with the Taliban over the aid provided by New Delhi.

'BJP is prepared to take strong decisions'

'BJP is prepared to take strong decisions'

Rediff.com26 Sep 2022

'In AAP, those who are in charge of a particular state provide information to Arvind Kejriwal. 'In the BJP, several organisations convey what is happening on the ground to the top leadership.' 'There are so many channels through which issues are being understood.'

'Infections are going to skyrocket'

'Infections are going to skyrocket'

Rediff.com1 Feb 2022

'And they are going to be milder because we are dealing with the vaccinated and are much richer in terms of the immune response in the population.'

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

Rediff.com19 Aug 2020

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year.

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

Hetero launches generic COVID-19 drug at Rs 59 per tablet

Hetero launches generic COVID-19 drug at Rs 59 per tablet

Rediff.com29 Jul 2020

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of COVID-19.

WHO classifies Indian Covid strain as 'variant of concern'

WHO classifies Indian Covid strain as 'variant of concern'

Rediff.com11 May 2021

The B-1617 variant of the coronavirus, first identified in India, has been classified as a variant of concern at the global level by the World Health Organisation (WHO).

US to send raw material to India for Covishield

US to send raw material to India for Covishield

Rediff.com26 Apr 2021

The Biden administration has come under criticism from several quarters, including from members and supporters of the Democratic party, for not releasing surplus COVID-19 vaccines to India when the country is experiencing its worst-ever public health crisis.